SE8603803D0 - Forbettringar avseende virala isolat och deras anvendning - Google Patents

Forbettringar avseende virala isolat och deras anvendning

Info

Publication number
SE8603803D0
SE8603803D0 SE8603803A SE8603803A SE8603803D0 SE 8603803 D0 SE8603803 D0 SE 8603803D0 SE 8603803 A SE8603803 A SE 8603803A SE 8603803 A SE8603803 A SE 8603803A SE 8603803 D0 SE8603803 D0 SE 8603803D0
Authority
SE
Sweden
Prior art keywords
retrovirus
antibody
globulin
bound
solid phase
Prior art date
Application number
SE8603803A
Other languages
English (en)
Swedish (sv)
Other versions
SE8603803L (sv
Inventor
R Weiss
R Cheingsong-Popov
R Tedder
B Ferns
Original Assignee
Cancer Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858500918A external-priority patent/GB8500918D0/en
Application filed by Cancer Res Inst filed Critical Cancer Res Inst
Publication of SE8603803D0 publication Critical patent/SE8603803D0/xx
Publication of SE8603803L publication Critical patent/SE8603803L/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81—Tube, bottle, or dipstick
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8603803A 1985-01-15 1986-09-11 Forbettringar avseende virala isolat och deras anvendning SE8603803L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858500918A GB8500918D0 (en) 1985-01-15 1985-01-15 Viral isolates
US75660485A 1985-07-19 1985-07-19
PCT/GB1986/000023 WO1986004423A1 (en) 1985-01-15 1986-01-13 Improvements relating to viral isolates and their use

Publications (2)

Publication Number Publication Date
SE8603803D0 true SE8603803D0 (sv) 1986-09-11
SE8603803L SE8603803L (sv) 1986-09-11

Family

ID=26288664

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603803A SE8603803L (sv) 1985-01-15 1986-09-11 Forbettringar avseende virala isolat och deras anvendning

Country Status (15)

Country Link
AT (1) ATA900186A (ja)
AU (1) AU591647B2 (ja)
BE (1) BE904030A (ja)
BR (1) BR8604533A (ja)
CH (1) CH675636A5 (ja)
DE (2) DE3690028T (ja)
DK (1) DK437386A (ja)
FI (1) FI863704A0 (ja)
FR (1) FR2576107B1 (ja)
GB (1) GB2179449B (ja)
HU (1) HU204929B (ja)
IT (1) IT1191841B (ja)
NL (1) NL8620004A (ja)
SE (1) SE8603803L (ja)
WO (1) WO1986004423A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500918D0 (en) * 1985-01-15 1985-02-20 Cancer Res Inst Viral isolates
EP0193284B1 (en) * 1985-02-05 1990-07-18 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce A method for detecting htlv-iii neutralizing antibodies in sera
AU579715B2 (en) * 1985-02-26 1988-12-08 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Detection of human t-cell leukemia virus type iii
US4748110A (en) * 1985-09-25 1988-05-31 Abbott Laboratories Immunoassay for HTLV-III antigens
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US6514691B1 (en) 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
US5364933A (en) * 1986-03-03 1994-11-15 Institut Pasteur Methods of immunopurification of antigens of human immunodeficiency virus type 2 (HIV-2)
CA1278259C (en) * 1986-02-26 1990-12-27 William C. Saxinger Competitive elisa for the detection of antibodies
US4904581A (en) * 1986-05-06 1990-02-27 Epitope, Inc. Method of detecting AIDS virus infection
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna
DE3877294T2 (de) * 1987-09-04 1993-05-06 Int Murex Tech Corp Festphasenimmunoassay fuer einen antikoerper und hierbei verwendete biologische produkte.
US5115098A (en) * 1990-02-28 1992-05-19 President And Fellows Of Harvard College End-blocked peptides inhibiting binding capacity of gp120

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016687B (en) * 1978-03-20 1982-09-08 Abbott Lab Sugar coated reagents for solid phase immunoassay
EP0136798A3 (en) * 1983-08-25 1986-02-19 Biotech Research Laboratories Inc. Titre plate and assay kit for detection of antibodies in human serum and their production and use
IE58321B1 (en) * 1984-04-23 1993-09-08 Us Health Isolation of proteins of HTLV-III, serological detection of antibodies to HTLV-III in sera of patients with aids and pre-aids conditions, and detection of HTLV-III infection bi/immuno-assays using HTLV-III infection by immuno-assays using HTLV-III and its proteins
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
US4520113A (en) * 1984-04-23 1985-05-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions
AU580425B2 (en) * 1985-05-24 1989-01-12 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Competitive elisa for the detection of antibodies

Also Published As

Publication number Publication date
GB2179449A (en) 1987-03-04
HUT41129A (en) 1987-03-30
FR2576107A1 (fr) 1986-07-18
BE904030A (fr) 1986-07-14
AU5238586A (en) 1986-08-13
DK437386D0 (da) 1986-09-12
BR8604533A (pt) 1987-07-14
WO1986004423A1 (en) 1986-07-31
AU591647B2 (en) 1989-12-14
DE3690028T (ja) 1987-03-12
HU204929B (en) 1992-02-28
SE8603803L (sv) 1986-09-11
GB8620371D0 (en) 1986-10-01
NL8620004A (nl) 1986-12-01
FI863704A (fi) 1986-09-12
GB2179449B (en) 1988-12-21
FR2576107B1 (fr) 1990-08-31
CH675636A5 (ja) 1990-10-15
DE3690028C2 (de) 1995-05-24
DK437386A (da) 1986-09-12
IT1191841B (it) 1988-03-23
ATA900186A (de) 1993-12-15
IT8619072A0 (it) 1986-01-13
FI863704A0 (fi) 1986-09-12

Similar Documents

Publication Publication Date Title
CA1335880C (en) Detection of an antibody and antigen in an immunoassay
US20190324039A1 (en) Method and devices for rapid diagnosis of foot-and-mouth disease
ATE113723T1 (de) Verfahren zur bestimmung von antikörpern.
US6063564A (en) Circulation thin layer liquid phase assay
JP3526873B2 (ja) プロテインａの内部コントロールを用いる分析装置及び免疫学的検定
SE8603803L (sv) Forbettringar avseende virala isolat och deras anvendning
JPH06100602B2 (ja) 抗イディオタイプのモノクローン抗体試薬を用いて、ジロフィラリア犬糸状虫感染の有無を決定するための免疫検定法
FI20021626A (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
ATE1614T1 (de) Immunologisches bestimmungsverfahren.
Portetelle et al. Use of monoclonal antibody in an ELISA test for the detection of antibodies to bovine leukaemia virus
Moritsugu et al. Hepatitis B core antigen: detection of antibody by radioimmunoprecipitation
DK0378175T3 (da) Diagnostisk påvisning under anvendelse af kimære antistoffer
DE3576854D1 (de) Immunchemisches messverfahren fuer haptene und proteine.
SE9000595L (sv) Nya peptider, diagnostiska antigener och ett immunanalysfoerfarande
EP1310796A2 (en) Reagents for the simultaneous detection of HCV core antigens and antibodies
KR890007076A (ko) 이종(Heterologous)유기체내에서 생성된 항원을 사용한 면역 검정방법
AU628293B2 (en) Self-contained multi-immunoassay diagnostic system
US7026133B2 (en) Method and composition for the diagnosis of equine infectious anemia virus disease by using the recombinant capsid protein virus (p26)
EP0951646B1 (en) THE IMMUNOENZIMATIC ASSAY FOR THE DIAGNOSIS OF EQUINE INFECTIOUS ANEMIA VIRUS DISEASE BY USING RECOMBINANT PROTEIN (rGP90) DERIVED FROM EQUINE INFECTIOUS ANEMIA VIRUS
Katz et al. Use of chicken and rabbit antibodies in a solid phase protein A radioimmunoassay for virus detection
AU729356B2 (en) The immunoenzimatic assay for the diagnosis of equine infectious anemia virus disease by using recombinant protein (rGP90) derived from equine infectious anemia virus
AU607177B2 (en) Hiv gp160 virus envelope protein-containing strips and use thereof for detection of aids antibody
DK0599803T3 (da) Fremgangsmåde til påvisning af antistoffer og antigener
Portetelle et al. Bovine Leukosis—Recent Developments with use of Monoclonal Antibodies and Elisa Tests
KR890005520A (ko) 응집반응 측정법

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8603803-1

Effective date: 19930820